Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Atzpodien

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Active specific immunotherapy of renal cell carcinoma: cellular and humoral immune responsesU Zorn, S Duensing, F Langkopf, et al.
Oncology|May 1, 1994
Treatment of metastatic colorectal cancer patients with 5-fluorouracil in combination with recombinant subcutaneous human interleukin-2 and alpha-interferonJ Atzpodien, H Kirchner, E L Hänninen, et al.
Urological Research|January 1, 1992
Effects of cytokines on growth in vitro of primary human renal cell carcinomaW de Riese, E P Allhoff, M Werner, et al.
Cancer Biotherapy|January 1, 1993
Limited efficacy of interferon-alpha and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinomaE Lopez Hanninen, M Fenner, H Kirchner, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 5, 2002
HLA phenotype and cytokine-induced tumor control in advanced renal cell cancerA Franzke, J Buer, M Probst-Kepper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2P A Palmer, J Vinke, T Philip, et al.
The Journal of Urology|July 20, 1999
In vivo description of dendritic cells in human renal cell carcinomaT Schwaab, A R Schned, J A Heaney, et al.
British Journal of Cancer|March 31, 1999
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinomaF Wittke, R Hoffmann, J Buer, et al.
British Journal of Cancer|March 5, 2002
Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cellsA Brinckmann, S Axer, D Jakschies, et al.
Cancer Investigation|January 1, 1989
In vitro chemopurification of neuroblastoma cells: comparison of 6-hydroxydopamine and ascorbic acid with 4-hydroperoxycyclophosphamideS C Gulati, J H Kwon, B Kushner, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Active specific immunotherapy of renal cell carcinoma: cellular and humoral immune responsesU Zorn, S Duensing, F Langkopf, et al.
Oncology|May 1, 1994
Treatment of metastatic colorectal cancer patients with 5-fluorouracil in combination with recombinant subcutaneous human interleukin-2 and alpha-interferonJ Atzpodien, H Kirchner, E L Hänninen, et al.
Urological Research|January 1, 1992
Effects of cytokines on growth in vitro of primary human renal cell carcinomaW de Riese, E P Allhoff, M Werner, et al.
Cancer Biotherapy|January 1, 1993
Limited efficacy of interferon-alpha and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinomaE Lopez Hanninen, M Fenner, H Kirchner, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 5, 2002
HLA phenotype and cytokine-induced tumor control in advanced renal cell cancerA Franzke, J Buer, M Probst-Kepper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2P A Palmer, J Vinke, T Philip, et al.
The Journal of Urology|July 20, 1999
In vivo description of dendritic cells in human renal cell carcinomaT Schwaab, A R Schned, J A Heaney, et al.
British Journal of Cancer|March 31, 1999
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinomaF Wittke, R Hoffmann, J Buer, et al.
British Journal of Cancer|March 5, 2002
Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cellsA Brinckmann, S Axer, D Jakschies, et al.
Cancer Investigation|January 1, 1989
In vitro chemopurification of neuroblastoma cells: comparison of 6-hydroxydopamine and ascorbic acid with 4-hydroperoxycyclophosphamideS C Gulati, J H Kwon, B Kushner, et al.
Pageof 12